Retraction: MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3 (PLoS ONE (2014) 6:10 (e109734) DOI: 10.1371/journal.pone.0109734);MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Xiu, Youcheng ^a,b   Liu, Zan ^b   Xia, Shunyao ^b   Jin, Chengjun ^b   Yin, Huaifu ^b   Zhao, Weiming ^b   Wu, Qiong ^a  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 137; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MIRN137 MICRORNA, HUMAN; RKTG PROTEIN, HUMAN; SIGNAL PEPTIDE;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; BLADDER CANCER; BLADDER CANCER CELL LINE; BLADDER CARCINOGENESIS; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PAQR3 GENE; PROTEIN BINDING; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION; BLADDER TUMOR; CELL MOTION; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84908032021     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0269903     Document Type: Erratum

References (40)

1. Sanchez-Carbayo M (2012) Urine epigenomics: a promising path for bladder cancer diagnostics. Expert Rev Mol Diagn 12: 429-432.
2. Adam L, Wszolek MF, Liu CG, Jing W, Diao L, et al. (2013) Plasma microRNA profiles for bladder cancer detection. Urol Oncol 31: 1701-1708.
3. Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP (2008) Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 10: 31-43.
4. Amling CL (2001) Diagnosis and management of superficial bladder cancer. Curr Probl Cancer 25: 219-278.
5. Bulbul MA, Husseini N, Houjaij A (2005) Superficial bladder cancer epidemiology, diagnosis and management. J Med Liban 53: 107-113.
6. Vinall RL, Ripoll AZ, Wang S, Pan CX, deVere White RW (2012) MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status. Int J Cancer 130: 2526-2538.
7. Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, et al. (2012) Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines. Int J Oncol 40: 951-959.
8. Jiang QQ, Liu B, Yuan T (2013) MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1. Asian Pac J Cancer Prev 14: 4127-4130.
9. Han Y, Liu Y, Zhang H, Wang T, Diao R, et al. (2013) Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett 587: 3875-3882.
10. Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, et al. (2011) MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 17: 3976-3985.
11. Guancial EA, Bellmunt J, Yeh S, Rosenberg JE, Berman DM (2014) The evolving understanding of microRNA in bladder cancer. Urol Oncol 32: 41 e31-40.
12. Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, et al. (2013) Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 10: 396-404.
13. Li Z, Lei H, Luo M, Wang Y, Dong L, et al. (2014) DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer.
14. Yu X, Li Z, Shen J, Wu WK, Liang J, et al. (2013) MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration. PLoS One 8: e83080.
15. Yang GH, Wang F, Yu J, Wang XS, Yuan JY, et al. (2009) MicroRNAs are involved in erythroid differentiation control. J Cell Biochem 107: 548-556.
16. Zhang Z, Chang H, Li Y, Zhang T, Zou J, et al. (2010) MicroRNAs: potential regulators involved in human anencephaly. Int J Biochem Cell Biol 42: 367-374.
17. Zheng B, Liang L, Wang C, Huang S, Cao X, et al. (2011) MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-7583.
18. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, et al. (2011) miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118: 6881-6892.
19. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, et al. (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 protooncogene in human invasive breast cancer. Cancer Res 71: 3552-3562.
20. Yoon SO, Chun SM, Han EH, Choi J, Jang SJ, et al. (2011) Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Hum Pathol 42: 1391-1400.
21. Yongchun Z, Linwei T, Xicai W, Lianhua Y, Guangqiang Z, et al. (2014) MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. Cancer Lett.
22. Khatri R, Subramanian S (2013) MicroRNA-135b and Its Circuitry Networks as Potential Therapeutic Targets in Colon Cancer. Front Oncol 3: 268.
23. Guo J, Xia B, Meng F, Lou G (2013) miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. Biochem Biophys Res Commun 441: 357-363.
24. Chen Q, Chen X, Zhang M, Fan Q, Luo S, et al. (2011) miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci 56: 2009-2016.
25. Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, et al. (2013) MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 4: 665-676.
26. Li P, Ma L, Zhang Y, Ji F, Jin F (2014) MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation. Biomed Pharmacother 68: 7-12.
27. Liang L, Li X, Zhang X, Lv Z, He G, et al. (2013) MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology 144: 624-635 e624.
28. Althoff K, Beckers A, Odersky A, Mestdagh P, Koster J, et al. (2013) MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. Int J Cancer 133: 1064-1073.
29. Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, et al. (2013) Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Eur Urol 63: 1091-1100.
30. Han Y, Liu Y, Zhang H, Wang T, Diao R, et al. (2013) Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1. FEBS Lett.
31. Wu WK, Lee CW, Cho CH, Fan D, Wu K, et al. (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29: 5761-5771.
32. Miao J, Wu S, Peng Z, Tania M, Zhang C (2013) MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol.
33. Yin J, Lin J, Luo X, Chen Y, Li Z, et al. (2014) miR-137: a new player in schizophrenia. Int J Mol Sci 15: 3262-3271.
34. Zhao Y, Li Y, Lou G, Zhao L, Xu Z, et al. (2012) MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS One 7: e39102.
35. Wang L, Wang X, Li Z, Xia T, Zhu L, et al. (2013) PAQR3 has modulatory roles in obesity, energy metabolism, and leptin signaling. Endocrinology 154: 4525-4535.
36. Feng L, Xie X, Ding Q, Luo X, He J, et al. (2007) Spatial regulation of Raf kinase signaling by RKTG. Proc Natl Acad Sci U S A 104: 14348-14353.
37. Fan F, Feng L, He J, Wang X, Jiang X, et al. (2008) RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Carcinogenesis 29: 1157-1163.
38. Zhang Y, Jiang X, Qin X, Ye D, Yi Z, et al. (2010) RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene 29: 5404-5415.
39. Jiang Y, Xie X, Li Z, Wang Z, Zhang Y, et al. (2011) Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition. Cancer Res 71: 2959-2968.
40. Wang X, Li X, Fan F, Jiao S, Wang L, et al. (2012) PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis 33: 2228-2235.